Currently set to Index
Currently set to Follow

Pan-European deal-by-deal Platform

Aescuvest makes it easy to become a shareholder in carefully selected European healthcare companies.

  • Fast & uncomplicated

    Committed capital can be immediately invested in excellent deal flow – no more waiting for drawdowns!

  • Healthcare Excellence

    Pre-selected, high-quality venture capital investments in tomorrow’s healthcare technology.

  • Personal & flexible

    Full control over the portfolio and customized service that can be adapted to your needs.

From Germany. For Europe.

  • 131 Applications

    In 2021, we had over 131 companies coming from 21 countries evaluated by our Investment Committee to select the best of Europe

  • > 15 Million Invested

    Over 15 Million Euros has been invested in MedTech, BioTech & Digital Health

    90 Million

    In 2022, we will raise up to 90 million Euros for the selected companies

How we select the best investment opportunities

  • Award Winners From
    EIT Health

    In partnership with EIT Health, we select the best companies among over 500 participants to their accelerator programs.

  • Investment Committee & Assessment

    Our Investment Committee screens the companies and we perform an assessment on the shortlisted companies to select the best opportunities for our investors.

  • The 5-5-10 Formula

    We aim to select companies that answer this formula:

    • 5 Million capital needed
    • 5 years
    • Factor 10 Return on Investment

Partner

Sounds interesting!

Stay up to date on the latest investment opportunities and news at Aescuvest

By clicking on 'Sign up', you agree to receive the newsletter with information on, for example, our services, our company as well as to its analysis through individual measurement, storage and evaluation of opening rates and click rates in recipient profiles for the purpose of designing future newsletters according to the interests of our readers. Consent can be revoked with effect for the future. Detailed information is available in our data privacy terms.

New from the blog